Nautilus Biotechnology NAUT
NASDAQ NAUT
$2.71 +0.16 (+6.27%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nautilus Biotechnology (NAUT) Receivables (2026)

Updated

Nautilus Biotechnology (NAUT) recorded Receivables of $100,000 in Q2 2026.

Analysis

Nautilus Biotechnology (NAUT) Receivables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 11.14 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 8.60 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 3.97 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 1.67 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 6.36 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 3.74 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 3.05 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 2.36 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 955.70 Mn
10 Nautilus Biotechnology 345.81 Mn -68.92 Mn 175,000.00 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
API Access

Nautilus Biotechnology Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NAUT&period=max&api_key=YOUR_API_KEY